ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $9,331,000 | +33.0% | 382,739 | -22.3% | 0.07% | +22.2% |
Q4 2018 | $7,017,000 | +23.3% | 492,427 | +31.5% | 0.05% | +45.9% |
Q3 2018 | $5,693,000 | +11.5% | 374,570 | +23.1% | 0.04% | +12.1% |
Q2 2018 | $5,104,000 | +12.3% | 304,200 | +9.2% | 0.03% | -8.3% |
Q1 2018 | $4,545,000 | +62.6% | 278,488 | +27.6% | 0.04% | +89.5% |
Q4 2017 | $2,795,000 | +34.6% | 218,328 | +29.3% | 0.02% | +26.7% |
Q3 2017 | $2,077,000 | +61.0% | 168,843 | +9.5% | 0.02% | +66.7% |
Q2 2017 | $1,290,000 | – | 154,170 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |